References
Louis DN, Ohgaki H, Wiestler OD (2016) Cavenee WKe. World Health Organization histological classification of Tumours of the central nervous system. Lyon, France, International Agency for Research on Cancer
Rodriguez FJ, Folpe AL, Giannini C, Perry A (2012) Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol 123:295–319
Thway K, Hamarneh W, Miah AB, Fisher C (2015) Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous and glandular elements: rare epithelial differentiation in a triton tumor. Int J Surg Pathol 23:377–383
Louis DN, Ohgaki H, Wiestler OD, Cavenee WKe (2016) World Health Organization histological classification of tumours of the central nervous system (Revised 4th Edition). In: Bosman FT, Jaffe ES, Lakhani SR, Ohgaki H (eds). International Agency for Research on Cancer, Lyon, France
Kang Y, Pekmezci M, Folpe AL et al (2014) Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma. Mod Pathol 27:55–61
Cruz J, Reis-Filho JS, Lopes JM (2004) Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma. J Clin Pathol 57:218–220
Lisa AC, Mark RW (2006) Immunohistology of soft tissue and osseous neoplasms. In: Dabbs DJ (ed). Diagnostic Immunohistochemistry, 2nd edition. Elsevier
Karamchandani JR, Nielsen TO, van de Rijn M, West RB (2012) Sox10 and S100 in the diagnosis of soft-tissue neoplasms. Appl Immunohistochem Mol Morphol 20:445–450
Pekmezci M, Reuss DE (2014) Hirbe AC et al. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas, Mod Pathol
Cleven AH, Sannaa GA, Briaire-de Bruijn I et al (2016) Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29:582–590
Schaefer IM, Fletcher CD, Hornick JL (2016) Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol 29:4–13
Bonetti B, Panzeri L, Carner M et al (1997) Human neoplastic Schwann cells: changes in the expression of neurotrophins and their low-affinity receptor p 75. Neuropathol Appl Neurobiol 23:380–386
Folpe AL, Schmidt RA, Chapman D, Gown AM (1998) Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 22:673–682
Fanburg-Smith JC, Miettinen M (2001) Low-affinity nerve growth factor receptor (p 75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues. Hum Pathol 32:976–983
Woodhoo A, Sommer L (2008) Development of the Schwann cell lineage: from the neural crest to the myelinated nerve. Glia 56:1481–1490
Nonaka M, Kohmura E, Hirata M, Hayakawa T (1998) Metastatic meningeal hemangiopericytoma of thoracic spine. Clin Neurol Neurosurg 100:228–230
Lazova R, Tantcheva-Poor I, Sigal AC (2010) P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma. J Am Acad Dermatol 63:852–858
Shivane A, Parkinson DB, Ammoun S, Hanemann CO (2013) Expression of c-Jun and sox-2 in human schwannomas and traumatic neuromas. Histopathology 62:651–656
Röhrich M, Koelsche C, Schrimpf D et al (2016) Methylation-based classification of benign and malignant peripheral nerve sheath tumors. Acta Neuropathol 131:877–887
Prieto-Granada CN, Wiesner T, Messina JL et al (2016) Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST. Am J Surg Pathol 40:479–489
Miller SJ, Rangwala F, Williams J et al (2006) Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Res 66:2584–2591
Miettinen M, McCue PA, Sarlomo-Rikala M et al (2015) Sox10--a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol 39:826–835
Rad E, Tee AR (2016) Neurofibromatosis type 1: fundamental insights into cell signalling and cancer. Semin Cell Dev Biol 52:39–46
Lee W, Teckie S, Wiesner T et al (2014) PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet 46:1227–1232
Stasik CJ, Tawfik O (2006) Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor). Arch Pathol Lab Med 130:1878–1881
Acknowledgments
The Authors wish to express their sincere gratitude to Prof Dr Bernd W. Scheithauer for his leading role in this study. Unfortunately he was not able to see the final product.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ersen, A., Pekmezci, M., Folpe, A.L. et al. Comparision of New Diagnostic Tools for Malignant Peripheral Nerve Sheath Tumors. Pathol. Oncol. Res. 23, 393–398 (2017). https://doi.org/10.1007/s12253-016-0125-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-016-0125-y